| Nr | QI 9 |
| Titel | 30-Tage-Mortalität nach Intervention |
| Zähler | Anzahl Patienten, die innerhalb von 30 Tagen postinterventionell verstorben sind |
| Nenner | Alle Patienten mit Erstdiagnose eines Nierenzell-Ca mit Nieren(teil)resektion oder ablativer Therapie (RFA, Kryotherapie) als Ersttherapie |
| Referenz Empfehlung | 30 Day Mortality After Surgery or Ablation Ausschlüsse: Emergency surgery (nephrectomy). Please Note: This QPI will be reported by treatment type as opposed to a single figure for all treatment options covered by the indicator (i.e. RFA, cryotherapy, SACT or surgery) Z: Number of patients who undergo minimally invasive or operative treatment as first treatment who die within 30 days N: All patients who undergo minimally invasive (RFA, cryotherapy, SACT) or operative treatment as first treatment for RCC. Zielvorgaben: < 5% (This target reflects the fact that death from any cause, rather than death from renal cancer is being measured by this indicator.) |
| Evidenzgrundlage/weitere informationen | Qualitätsziel: <5% Anmerkungen: Quelle: Scottish Cancer Taskforce. Renal Cancer Clinical Quality Performance Indicators. Published: January 2012. Updated: December 2014 (v2.1)Published by: Healthcare Improvement http://www.healthcareimpr ovementscotland.org/his/i doc.ashx?docid=211c7043 -6d86-4417-acee3296e0bfb7bd&version=-1 (Stand: 29.06.2015) |
| Anmerkungen |